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Sclerosing mesenteritis is a rare benign process that involves inﬂammation, fat necrosis, and ﬁbrosis of the mesentery. The disease
poses great diagnostic challenge due to its nonspeciﬁc clinical and diagnostic ﬁndings. We report the case of a 75-year-old man
who presented with vague abdominal discomfort associated with an intra-abdominal mass. With suspicion of a bowel carcinoid
tumor on computed tomography scans, the patient underwent diagnostic laparoscopy. A diagnosis of sclerosing mesenteritis was
made on histological examination. The patient’s symptoms responded to a combination of immunosuppressive drugs, with no
interval change in the size of the mass on radiological examination after ﬁfteen months.
1.Introduction
Sclerosing mesenteritis is deﬁned as a rare, benign process
involving mesenteric adipose tissue [1]. Mostly aﬀecting
adults of middle age or older, it has been reported twice as
o f t e ni nm e nt h a ni nw o m e n[ 2]. Three types of pathological
changes have been described within the mass, which include
fat necrosis, chronic inﬂammation, and ﬁbrosis [3, 4].
Various terms have been used to describe the condition and
these include mesenteric lipodystrophy, retractile or liposcle-
rotic mesenteritis, mesenteric Weber-Christian disease, xan-
thogranulomatous mesenteritis, mesenteric lipogranuloma,
and systemic nodular panniculitis [4]. However, depending
on the predominant histological features which include fat
necrosis, inﬂammation, or ﬁbrosis and retraction, the condi-
tion is referred to as mesenteric lipodystrophy, panniculitis
or retractile mesenteritis, respectively [4]. Due to varied
and non-speciﬁc presentations and ﬁndings, the disease
poses great diagnostic challenges leading to misdiagnosis in
majority of the cases. Although deﬁnitive diagnosis requires
biopsy and histopathology, various radiological modalities
such as multidetector CT and MRI have been used to make
the diagnosis with appropriate clinical analysis.
We report a case of a 75-year-old gentleman, who
presented with vague abdominal discomfort and an intra-
abdominal mass. Secondary to a strong suspicion of a bowel
carcinoid tumor on abdominal CT scan, he underwent a
diagnostic laparoscopy and minilaparotomy. A diagnosis of
sclerosing mesenteritis was made on histopathology and the
patient was started on an immunosuppressive regimen.
2. Case Presentation
A 75 years old male patient, presented to the outpatient
department with a 3-month history of vague abdominal
discomfort (stretching sensation in the upper abdomen) and
an intra-abdominal mass “about the size of his ﬁst” which he
believed had gradually increased in size over the previous 2
months. On examination the mass was found to be located
above the umbilicus; it was mobile, smooth, approximately
6 × 7 × 5cm and slightly tender on deep palpation. The2 Case Reports in Medicine
baseline laboratory workup consisted of routine blood tests
including hepatic and renal function tests which were all
unremarkable. An abdominal CT scan with IV contrast
revealed a heterogeneous, soft tissue, mesenteric mass with
calciﬁcations in the root of the mesentery, encasing the
superior mesenteric vessel. Mesenteric ﬁbrosis resulting in
tethering of small bowel loops with extensive desmoplastic
reaction and small mesenteric lymph nodes were also noted
(Figures 1(a), 1(b),a n d1(c)).
With high suspicion of bowel carcinoid tumor by the
radiologist (although a diﬀerential diagnosis of ﬁbrosing
mesenteritis was also suggested), a diagnostic laparoscopy
was performed. Intraoperatively, the mass was found to be
located in the paraaortic region, at the root of mesentery.
Because the friable lesion bled easily on touch, the procedure
was converted to a minilaparotomy.
A wedge of the mass was taken for histopathology
examination which revealed extensive ﬁbrosis along with a
few areas of necrosis. Occasional collections of histiocytes
were noted, but no evidence of granuloma or malignancy
was identiﬁed (Figures 2(a) and 2(b)). The diagnosis of
sclerosing mesenteritis was made and the patient was started
on a regimen of immunosuppressive drugs which included
prednisolone and azathioprine, along with tamoxifen. Over
the past 30 months, the patient has been on tamoxifen and
azathioprine. Tamoxifen has been shown to be useful in the
treatment of desmoid tumors and idiopathic retroperitoneal
ﬁbrosis [5]. Another reason for combining tamoxifen with
the immunosuppressive regimen was that this drug is
relatively safe and simple to dose.
Prednisolone has been tapered oﬀ and restarted twice
over this time, depending on the symptoms which include
feeling of stretch in the abdomen and lack of appetite.
Follow-upCTscansoftheabdomenat2,6,8,and15months
afterthebiopsyrevealednointervalchangeintheappearance
of the mass. The patient had been on the speciﬁed regimen
until he developed herpes zoster along the left mandibular
division of the trigeminal nerve. This required stopping
azathioprine. However, over a period of 6 weeks, this led to
worsening of symptoms and both steroids and azathioprine
had to be restarted. Currently, he is stable clinically and his
steroids are being tapered oﬀ.
3. Discussion
Sclerosing mesenteritis (SM) is a rare, benign, and chronic
inﬂammatory disorder of the small and large bowel
mesentery. Rarely, it may aﬀect the peripancreatic region,
omentum, retroperitoneum, and pelvis [2, 4]. The vast
majorityofthecasesareidiopathic,however,somecaseshave
been found to be associated with autoimmunity, ischemia,
infection, vasculitis, Gardner’s syndrome, carcinoid,
trauma, previous abdominal surgery, and various cancers
[6–10].
The clinical manifestations are largely non-speciﬁc. The
patient may be absolutely asymptomatic with diagnosis
made incidentally. Other ﬁndings may include, vague
abdominal discomfort and a palpable mass (as in the case
discussed), distention, progressive fatigue, weight loss, nau-
sea and vomiting, tender mass in the abdomen, fever, malab-
sorption syndrome, chylous ascites, and pneumoperitonium
[2, 4, 6, 10–12]. Laboratory workup such as complete blood
count,peripheralbloodﬁlm,erythrocytesedimentationrate,
serum C-reactive protein, amylase, lipase, liver and renal
function tests, and autoimmune workup is usually negative
in cases of pure sclerosing mesenteritis [4, 13, 14]a sw a s
observed in our patient.
CT ﬁndings associated with sclerosing mesenteritis are
variable. It may be seen as a subtle increased attenuation
to a solid soft-tissue mass in the small bowel mesentery.
Other ﬁndings include, enveloping of and preservation of fat
aroundthemesentericvessels,aphenomenonthatisreferred
to as the “fat ring sign” [15]. Several conditions can mimic
the CT appearance of sclerosing mesenteritis, including lym-
phoma, carcinoid tumor, carcinomatosis, primary mesen-
teric mesothelioma, mesenteric ﬁbromatosis, and mesenteric
edema. In the case described, the patient’s initial CT scan
was suggestive of a sclerosing mesenteritis. The inability to
distinguish it from a carcinoid tumor of the bowel warranted
obtaining a tissue sample for histopathological study [16].
Although CT and MRI scans may suggest the diagnosis
of sclerosing meseneteritis, the deﬁnitive diagnosis requires
biopsy and histological evaluation as it is imperative to
exclude an underlying infection or malignancy.
No generalized consensus has been reached so far
regarding the management of sclerosing mesenteritis. It
may be diﬃcult to distinguish it from other bowel dis-
eases and tumors preoperatively on radiological scans.
Intraoperatively, repetitive frozen section examinations may
reveal nonspeciﬁc inﬂammatory changes alone. Therefore,
due to the possibility of misdiagnosis preoperatively and
intraoperatively, it is sometimes required to remove the mass
surgically in order to avoid repetitive operations [14].
Surgery may also be attempted if medical therapy fails
or in the presence of life threatening complications such as
bowel obstruction or perforation [17]. In cases of colonic
involvement by sclerosing mesenteritis, a colostomy may be
necessary because complete surgical resection is often not
technically possible. However, the surgical approach is often
limited by vascular involvement [18].
Watchful waiting alone may suﬃce in cases where fat
necrosis is the main feature [11]. However, in cases where
features of chronic inﬂammation predominate, several ther-
apeutic agents have shown promising results. These include
cyclophosphamide [19] along with combined corticosteroids
and tamoxifen [2], and combined corticosteroids and aza-
thioprin [20]. A 30 months follow up of our patient reveals
good therapeutic outcome on the stated immunosuppressive
regimen in terms of no increase in the size of the mass.
However, once the mass acquires an aggressive course with
progressive ﬁbrosis and complications such as shortening of
mesentery, intestinal obstruction, perforation and vascular
compromise, complete surgical resection of the diseased
mesentery becomes mandatory [11, 21].
Kipfer et al. reports [22] a coexistent malignant lym-
phoma in 8 of the 53 patients ultimately. The co existence
of lymphomas has also been reported by others [23],Case Reports in Medicine 3
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Figure 1: Sclerosing mesenteritis. (a) Contrast enhanced CT Axial section through the mid abdomen shows a heterogeneous soft tissue
density (black arrow) with calciﬁcations in the root of mesentery and mesenteric fat stranding with ﬁbrotic kinking and traction over small
bowel loops as shown by an asterisk. (b) Contrast enhanced CT coronal section redemonstrating ﬁbrosing reaction in the mesentery with
pullingof adjacent bowel loops. (c) Contrastenhanced CT sagittal section clearly showing speculation in the mesenteric mass (straight white
arrow) with mesenteric fat inﬁltration.
(a) (b)
Figure 2:(a)(H&E,magniﬁcation10×).Densecollagen withfascicles ofblandﬁbroblasts.(b)(H&E,magniﬁcation 10×).Collagenbundles
with associated ﬁbroblasts and chronic inﬂammatory cells.
justifyingtheclinicalimportanceoftheearlydiagnosisofthis
condition. The overall prognosis of sclerosing mesenteritis is
usually very good with a benign and self limiting course in
most of the cases [1–3]. The pain disappears in 75% patients
and mass regresses in 66%, usually within 2 years [24].
4. Conclusion
Our case illustrates that the diagnosis of sclerosing mesen-
teritis can be diﬃcult preoperatively. Tissue diagnosis is
absolutely essential to avoid misdiagnosing a malignancy as
sclerosing mesenteritis on radiological appearance. Judicious
use of immunosuppressive therapy can limit progression of
the condition, delaying the need for surgery.
Consent
Written informed consent was obtained from the patient for
publication of this case report and accompanying images.
A copy of the written consent is available for review by the
Editor-in-Chief of this journal.
Competing Interests
The authors declare that they have no competing interests.
Authors’ Contributions
F. N. Ali conceived the idea of the manuscript, and was
a major contributor in data collection and writing the4 Case Reports in Medicine
manuscript. S. Ishaque participated in the data collection
and sequencing and drafting of the manuscript. B. Jamil was
involved in direct clinical care of the patient, therapeutic
planning, interpretation of the patient data and providing
overall supervision in the project. N.-U. Din was involved
in the interpretation of histopathology slides. M. Idris was
involvedintheinterpretationoftheCTscan.Allauthorsread
and approved the ﬁnal manuscript.
Abbreviations
SM: Sclerosing Mesenteritis
CT: Computed tomography
MRI: Magnetic resonance imaging
IV: Intravenous
H&E: Hematoxylin and Eosin stain.
References
[1] B.White,A.Kong,andA.-L.Chang,“Sclerosing mesenteritis,”
Australasian Radiology, vol. 49, no. 2, pp. 185–188, 2005.
[2] S. Akram, D. S. Pardi, J. A. Schaﬀn e r ,a n dT .C .S m y r k ,
“Sclerosing mesenteritis: clinical features, treatment, and
outcomeinninety-twopatients,”ClinicalGastroenterologyand
Hepatology, vol. 5, no. 5, pp. 589–596, 2007.
[3] C. I. Gonz´ alez Rodr´ ı g e z ,M .C i r e s ,T .R u b i o ,F .J .J i m ´ enez, I.
Garc´ ıa de Eulate, and M. T. Artondo, “A case of mesenteric
panniculitis,” Anales del Sistema Sanitario de Navarra, vol. 31,
no. 1, pp. 81–85, 2008.
[4] N. Vettoretto, D. R. Diana, R. Poiatti, A. Matteucci, C.
Chioda, and M. Giovanetti, “Occasional ﬁnding of mesenteric
lipodystrophyduringlaparoscopy:adiﬃcultdiagnosis,”World
Journal of Gastroenterology, vol. 13, no. 40, pp. 5394–5396,
2007.
[5] I. Ergun, K. Keven, B. Canbakan, Y. Ekmekci, and B. Erbay,
“Tamoxifen in the treatment of idiopathic retroperitoneal
ﬁbrosis,” Int Urol Nephrol, vol. 37, no. 2, pp. 341–343, 2005.
[6] A. L. Durst, H. Freund, E. Rosenmann, and D. Birnbaum,
“Mesenteric panniculitis: review of the literature and presen-
tation of cases,” Surgery, vol. 81, no. 2, pp. 203–211, 1977.
[7] R.Cuﬀ,J.Landercasper,andS.Schlack,“Sclerosingmesenteri-
tis,” Surgery, vol. 129, no. 4, pp. 509–510, 2001.
[8] V. Sharma, P. Martin, and V.-M. Marjoniemi, “Idiopathic
orbital inﬂammation with sclerosing mesenteritis: a new
association?” Clinical and Experimental Ophthalmology, vol.
34, no. 2, pp. 190–192, 2006.
[ 9 ] S .Y .H a n ,R .E .K o e h l e r ,a n dF .S .K e l l e r ,“ R e t r a c t i l em e s e n t e r i -
tis involving the colon: pathologic and radiologic correlation
(case report),” AmericanJournal ofRoentgenology, vol.147, no.
2, pp. 268–270, 1986.
[10] T. S. Emory, J. M. Monihan, N. J. Carr, and L. H. Sobin, “Scle-
rosing mesenteritis, mesenteric panniculitis and mesenteric
lipodystrophy: a single entity?” American Journal of Surgical
Pathology, vol. 21, no. 4, pp. 392–398, 1997.
[11] S. Chawla, S. Yalamarthi, I. A. Shaikh, V. Tagore, and P.
Skaife, “An unusual presentation of sclerosing mesenteritis
as pneumoperitoneum: case report with a review of the
literature,”WorldJournalofGastroenterology,v ol.15,no .1,pp .
117–120, 2009.
[12] M. Arora and E. Dubin, “A clinical case study: Sclerosing
mesenteritis presenting as chylous ascites,” MedGenMed Med-
scape General Medicine, vol. 10, no. 2, Article ID 30, 2008.
[13] A. M. Zafar, M. A. Rauf, T. Chawla, and G. Khanda,
“Mesenteric panniculitis with pedal edema in a 33-year-old
Pakistani man: a case report and literature review,” Journal of
Medical Case Reports, vol. 2, Article ID 365, 2008.
[14] G. L. Gu, S. L. Wang, X. M. Wei, L. Ren, D. C. Li, and F.
X. Zou, “Sclerosing mesenteritis as a rare cause of abdominal
pain and intraabdominal mass: a case report and review of the
literature,” Cases Journal, vol. 1, no. 1, p. 242, 2008.
[15] K. M. Horton, L. P. Lawler, and E. K. Fishman, “CT ﬁndings
in sclerosing mesenteritis (panniculitis): spectrum of disease,”
Radiographics, vol. 23, no. 6, pp. 1561–1567, 2003.
[16] J.E.Hamrick-Turner,M.V.Chiechi,P.L.Abbitt,andP.R.Ros,
“Neoplastic and inﬂammatory processes of the peritoneum,
omentum, and mesentery: diagnosis with CT,” Radiographics,
vol. 12, no. 6, pp. 1051–1068, 1992.
[17] I. Issa and H. Baydoun, “Mesenteric panniculitis: various
presentations and treatment regimens,” World Journal of
Gastroenterology, vol. 15, no. 30, pp. 3827–3830, 2009.
[18] A. L. Durst, R. Yarom, and E. M. Luttwak, “Malignant ﬁbro-
matous peritoneal mesothelioma associated with liposclerotic
mesenteritis,” American Journal of Gastroenterology, vol. 55,
no. 5, pp. 477–481, 1971.
[ 1 9 ]R .W .B u s h ,S .P .H a m m a r ,a n dR .H .R u d o l p h ,“ S c l e r o s i n g
mesenteritis. Response to cyclophosphamide,” Archives of
Internal Medicine, vol. 146, no. 3, pp. 503–505, 1986.
[ 2 0 ]A .B a l a ,S .P .C o d e r r e ,D .R .E .J o h n s o n ,a n dV .N a y a k ,
“Treatment of sclerosing mesenteritis with corticosteroids and
azathioprine,” Canadian Journal of Gastroenterology, vol. 15,
no. 8, pp. 533–535, 2001.
[21] C. Nobili, L. Degrate, R. Caprotti et al., “Extensive sclerosing
mesenteritis of the rectosigmoid colon associated with erosive
colitis,” Gastroenterology Research and Practice, vol. 2009,
Article ID 176793, 4 pages, 2009.
[22] R. E. Kipfer, C. G. Moertel, and D. C. Dahlin, “Mesenteric
lipodystrophy,” Annals of Internal Medicine,v o l .8 0 ,n o .5 ,p p .
582–588, 1974.
[23] A. L. Durst, H. Freund, E. Rosenmann, and D. Birnbaum,
“Mesenteric panniculitis: review of the literature and presen-
tation of cases,” Surgery, vol. 81, no. 2, pp. 203–211, 1977.
[24] M. Reske and H. Namiki, “Sclerosing mesenteritis. Report of
two cases,” American Journal of Clinical Pathology, vol. 64, no.
5, pp. 661–667, 1975.